Summary
Traditional microbiological culture for Legionella bacteria takes up to 14 days to provide a result. While some rapid methodologies have been developed they require 2-3 tests to be completed meaning it can take 3 days for a result and they also require capital investments in costly specialised equipment.
Bio-LP-1 is a novel rapid test which has the capacity to transform the environmental global testing landscape for the human pathogen Legionella.
Bio-LP-1’s unique selling point is that it provides a complete identification of Legionella to the serogroup level in a single test using molecular technologies.
This is a diagnostic breakthrough, as all existing competitors can only offer 2 or 3 stage molecular tests to generate the equivalent result. The single test Bio-LP-1 product format is 5 x FASTER than the nearest competitor, Offers €319,200 pa savings for large test laboratories conducting at least 50,000 tests per year. Bio-LP-1 – offers a faster time to result; yields more robust information; requires less hands on time; requires no specialised equipment and ultimately has the potential for significant cost savings.
Current estimates predict that the global legionella testing market will reach $352.6 million by 2025 and that the water testing market is the fastest growing sector.
We have a best in class consortium:
BPD - European experts in development and commercialisation of rapid microbial diagnostic solutions.
myPOLs - leader in molecular biology reagent manufacturing.
Genaxxon - European leader in sales of innovative molecular IVD products)
Control Microbiológico - ENAC accredited large environmental testing laboratory.)
BPD and myPOLS have previously collaborated in the development of Bio-Lp-1, over past 12 months to bring Bio-LP-1 to TRL 6
Bio-LP-1 is a novel rapid test which has the capacity to transform the environmental global testing landscape for the human pathogen Legionella.
Bio-LP-1’s unique selling point is that it provides a complete identification of Legionella to the serogroup level in a single test using molecular technologies.
This is a diagnostic breakthrough, as all existing competitors can only offer 2 or 3 stage molecular tests to generate the equivalent result. The single test Bio-LP-1 product format is 5 x FASTER than the nearest competitor, Offers €319,200 pa savings for large test laboratories conducting at least 50,000 tests per year. Bio-LP-1 – offers a faster time to result; yields more robust information; requires less hands on time; requires no specialised equipment and ultimately has the potential for significant cost savings.
Current estimates predict that the global legionella testing market will reach $352.6 million by 2025 and that the water testing market is the fastest growing sector.
We have a best in class consortium:
BPD - European experts in development and commercialisation of rapid microbial diagnostic solutions.
myPOLs - leader in molecular biology reagent manufacturing.
Genaxxon - European leader in sales of innovative molecular IVD products)
Control Microbiológico - ENAC accredited large environmental testing laboratory.)
BPD and myPOLS have previously collaborated in the development of Bio-Lp-1, over past 12 months to bring Bio-LP-1 to TRL 6
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/950822 |
| Start date: | 01-04-2020 |
| End date: | 31-07-2022 |
| Total budget - Public funding: | 2 826 040,00 Euro - 1 978 228,00 Euro |
Cordis data
Original description
Traditional microbiological culture for Legionella bacteria takes up to 14 days to provide a result. While some rapid methodologies have been developed they require 2-3 tests to be completed meaning it can take 3 days for a result and they also require capital investments in costly specialised equipment.Bio-LP-1 is a novel rapid test which has the capacity to transform the environmental global testing landscape for the human pathogen Legionella.
Bio-LP-1’s unique selling point is that it provides a complete identification of Legionella to the serogroup level in a single test using molecular technologies.
This is a diagnostic breakthrough, as all existing competitors can only offer 2 or 3 stage molecular tests to generate the equivalent result. The single test Bio-LP-1 product format is 5 x FASTER than the nearest competitor, Offers €319,200 pa savings for large test laboratories conducting at least 50,000 tests per year. Bio-LP-1 – offers a faster time to result; yields more robust information; requires less hands on time; requires no specialised equipment and ultimately has the potential for significant cost savings.
Current estimates predict that the global legionella testing market will reach $352.6 million by 2025 and that the water testing market is the fastest growing sector.
We have a best in class consortium:
BPD - European experts in development and commercialisation of rapid microbial diagnostic solutions.
myPOLs - leader in molecular biology reagent manufacturing.
Genaxxon - European leader in sales of innovative molecular IVD products)
Control Microbiológico - ENAC accredited large environmental testing laboratory.)
BPD and myPOLS have previously collaborated in the development of Bio-Lp-1, over past 12 months to bring Bio-LP-1 to TRL 6
Status
CLOSEDCall topic
EIC-FTI-2018-2020Update Date
26-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
